Table 3.

Percentage of Respondents Routinely Providing Adult Vaccines On Site (n = 612)

VaccineProviding On Site
MMR=measles-mumps-rubella; Td=tetanus toxoid/reduced-strength diphtheria toxoid; Tdap = tetanus toxoid/reduced-strength diphtheria toxoid and acellular pertussis.
a Did not specify meningococcal conjugate vaccine or meningococcal polysaccharide vaccine.
Hepatitis A virus65.3
Hepatitis A and B combination30.6
Hepatitis B virus83.6
Human papillomavirus77.4
Influenza91.9
MMR73.0
Meningococcala70.5
Pneumococcal pneumonia92.7
Td85.7
Tdap81.9
Herpes zoster59.1